Skip to main content
CAI logo
CAI
(NASDAQ)
Caris Life Sciences, Inc.
$26.05-- (--)
Loading... - Market loading

Caris Life Sciences (CAI) Stock Price & Financial Analysis

Caris Life Sciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$25.80 - $28.68
52-Week High$35.20
52-Week Low$14.19
Open$25.80
Volume8.65M
Average Volume (3M)5.30M
Market Cap7.37B
Shares Outstanding282.89M
P/E Ratio (TTM)70.09
Price to Sales (P/S)7.45
Price to Book (P/B)12.45
EV/EBITDA60.81
Revenue (TTM)989.61M
Net Income (TTM)105.14M
Free Cash Flow (TTM)123.96M
EPS (TTM)$0.17
Profit Margin10.62%
Operating Margin15.49%
Return on Equity (ROE)1.08%
Debt to Equity0.12
50-Day MA$20.35
200-Day MA$20.95
52-Week Change-28.02%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateJun 9, 2021

Frequently Asked Questions About Caris Life Sciences

What is the current stock price for CAI?

As of the latest trading session, CAI stock trades at $28.50. The 52-week range is $14.19–$35.20, with a day range of $25.80–$28.68.

What is the P/E ratio for CAI?

Caris Life Sciences's trailing P/E ratio is 70.1, meaning investors pay $70.1 for every $1 of annual earnings. Caris Life Sciences operates in the Healthcare sector.

Does CAI pay dividends?

Caris Life Sciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CAI?

Based on 6 analysts, the consensus for CAI is Buy.

What is the market cap of CAI?

Caris Life Sciences's market capitalization is $8.06B, classifying it as a mid-cap company. Caris Life Sciences operates in the Healthcare sector within the Biotechnology industry.